1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Renal Denervation Catheters Overview
3 Products under Development
3.1 Renal Denervation Catheters - Pipeline Products by Stage of Development
3.2 Renal Denervation Catheters - Pipeline Products by Segment
3.3 Renal Denervation Catheters - Pipeline Products by Territory
3.4 Renal Denervation Catheters - Pipeline Products by Regulatory Path
3.5 Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
3.6 Renal Denervation Catheters - Ongoing Clinical Trials
4 Renal Denervation Catheters - Pipeline Products under Development by Companies
4.1 Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
4.2 Renal Denervation Catheters - Pipeline Products by Stage of Development
5 Renal Denervation Catheters Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Ablative Solutions Inc Company Overview
5.2.1 Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AngioCare BV Company Overview
5.3.1 AngioCare BV Pipeline Products & Ongoing Clinical Trials Overview
5.4 Brattea Company Overview
5.4.1 Brattea Pipeline Products & Ongoing Clinical Trials Overview
5.5 CryoMedix, LLC. Company Overview
5.5.1 CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Handok-Kalos Medical Company Overview
5.6.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
5.7 Johns Hopkins University Company Overview
5.7.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Kona Medical Inc Company Overview
5.8.1 Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.9.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.10.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Mayo Clinic Company Overview
5.11.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.12 Medtronic Plc Company Overview
5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.13 MicroPort Scientific Corp Company Overview
5.13.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Northwind Medical Inc Company Overview
5.14.1 Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 ReCor Medical Inc Company Overview
5.15.1 ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Renal Dynamics, LLC Company Overview
5.16.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Renaly Ltd Company Overview
5.17.1 Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.18.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 Shanghai Golden Leaf Medtech Co Ltd Company Overview
5.19.1 Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 SoniVie Inc Company Overview
5.20.1 SoniVie Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Sound Interventions, Inc. Company Overview
5.21.1 Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.22 St. Jude Medical LLC Company Overview
5.22.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 Suzhou SyMap Medical Ltd Company Overview
5.23.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 Symple Surgical Inc Company Overview
5.24.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Tel Aviv University Company Overview
5.25.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Terumo Interventional Systems Company Overview
5.26.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.27 University of Sydney Company Overview
5.27.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.28 Verve Medical, Inc. Company Overview
5.28.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Renal Denervation Catheters- Recent Developments
6.1 Sep 21, 2021: PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner
6.2 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.3 Aug 12, 2021: PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
6.4 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.5 Aug 02, 2021: PAVmed to Hold Business Update Conference Call on August 12, 2021
6.6 Jul 28, 2021: Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
6.7 Jun 14, 2021: Tim Baxter Joins PAVmed Board of Directors
6.8 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.9 May 17, 2021: PAVmed Provides Business Update and First Quarter 2021 Financial Results
6.10 May 06, 2021: PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
6.11 May 03, 2021: PAVmed to Hold Business Update Conference Call on May 17 2021
6.12 Apr 29, 2021: Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
6.13 Apr 27, 2021: Global Industry Executive Debbie White Joins PAVmed Board of Directors
6.14 Feb 18, 2021: PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
6.15 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.16 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.17 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.18 Feb 09, 2021: PAVmed to Hold Business Update Conference Call on February 22, 2021
6.19 Feb 04, 2021: Terumo announce Financial Statements
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer